IRCT20200725048200N1 IRCT 2020-08-11 Gastrointestinal and Liver Diseases Research Center, Tabriz University of Medical Sciences Evaluation of the efficacy of Cranbery in treatment of Fatty Liver Evaluation of the efficacy of Cranbery in management of non-alcoholic Fatty Liver Patients 2020-07-27 anticipated 94 Complete https://irct.ir/trial/49884 interventional Randomization: Not randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Blinding description: Participants will receive cranberry extract and placebo as a double-sided blind. 3 Non-alcoholic fatty liver. Intervention 1: Intervention group: The first intervention group includes patients with grade 1, 2 and 3 liver.Cranberry extract is called Cranberry Shari, which is the brand name.Ingredients of its formulation 144 mg of cranberry fruit extract (Vaccinium Macrocarporn)،Standardized based on the presence of 25% proanthocyanidin، Equivalent to 36 mg of active ingredient (equivalent to 13 g of dried cranberry fruit).Patients will receive one daily, preferably with food, for 6 months. Possible side effects of the drug include gastrointestinal disorders (nausea and vomiting) and diarrhea (if taken in large amounts) explained to patients in the first session and then in the next sessions the referral will be asked about its possibility. Intervention 2: Control group: The second intervention group includes patients with grade 1, 2 and 3 liver who will receive one placebo daily for 6 months. The duration of use, the manner of consumption of patient education and follow-up of patients will be completely according to the patients receiving the main drug. Yes - There is a plan to make this available What will be shared: In this study, patients' identities are not shared. When: Access period starts 12 months after the results are published. To whom: Data will only be available to researchers in this study. Conditions: The data will be available to researchers only for meta-analysis study and for data analysis. Where to obtain: Receipt of data will be done through the scientific respondent of the study. How to obtain: To receive the data, an email is sent to the scientific respondent and the reason for receiving the data is mentioned in detail and if the reasons are appropriate, the information will be sent. Comments: